AMGEN ANNOUNCES WEBCAST OF 2022 MORGAN STANLEY GLOBAL HEALTHCARE CONFERENCE
Amgen (NASDAQ:AMGN) will present at the Morgan Stanley 2022 Global Healthcare Conference on Sept. 13, 2022, at 9:10 a.m. ET. CEO Robert A. Bradway will lead the discussion. The event will be webcasted live and accessible to the public. Recorded presentations and updates about Amgen can be found on their website under the Investors section. Amgen, a biotechnology leader since 1980, focuses on innovative therapeutics for serious illnesses, and is part of the Dow Jones Industrial Average and Nasdaq-100 index.
- Amgen is scheduled to present at a major healthcare conference, which may enhance visibility.
- CEO's presentation could strengthen investor confidence and communication.
- None.
THOUSAND OAKS, Calif., Sept. 8, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Morgan Stanley's 2022 Global Healthcare Conference at 9:10 a.m. ET on Tuesday, Sept. 13, 2022. Robert A. Bradway, chairman and chief executive officer at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.
The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.
About Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index. In 2021, Amgen was named one of the 25 World's Best Workplaces™ by Fortune and Great Place to Work™ and one of the 100 most sustainable companies in the world by Barron's.
For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.
CONTACT: Amgen, Thousand Oaks
Megan Fox, 805-447-1423 (media)
Jessica Akopyan, 805-447-0974 (media)
Arvind Sood, 805-447-1060 (investors)
View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-announces-webcast-of-2022-morgan-stanley-global-healthcare-conference-301620837.html
SOURCE Amgen
FAQ
When will Amgen present at the Morgan Stanley 2022 Global Healthcare Conference?
Who is presenting on behalf of Amgen at the conference?
Where can I watch the Amgen conference presentation?
Is the Amgen conference presentation open to the public?
What is Amgen's stock symbol?
